U.S. Food Stock News

Primoris Services Corporation ( NYSE:PRIM ) investors will be delighted, with the company turning in some strong...

Despite posting healthy earnings, ACCO Brands Corporation's ( NYSE:ACCO ) stock has been quite weak. We have done some...

Key Insights Arq's significant individual investors ownership suggests that the key decisions are influenced by...

The market shrugged off Cooper-Standard Holdings Inc.'s ( NYSE:CPS ) solid earnings report. We think that investors...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Alto Ingredients, Inc. ( NASDAQ:ALTO ) shares have continued their recent momentum with a 28% gain in the last month...

Key Insights Given the large stake in the stock by institutions, ADC Therapeutics' stock price might be vulnerable to...

Earlier this week, Nordson director Milton Morris Mayo sold US$61,000 worth of shares and received 822 Restricted Share Units that will vest in 2026. Alongside several recent insider sales, analysts have maintained positive ratings, citing stronger-than-expected operating results and improved company guidance in the face of healthy demand. We’ll explore how Nordson’s improved company guidance and analyst optimism may shape the company’s investment outlook moving forward. Uncover the next big...

Kingsoft Cloud Holdings (NasdaqGS:KC) recently boosted its issued shares by 338 million, highlighting efforts to improve its market standing and set the stage for long-term growth, particularly through AI and ecosystem partnerships. See our latest analysis for Kingsoft Cloud Holdings. Kingsoft Cloud's 1-year total shareholder return of 177.31% outpaces its recent 1-month share price pullback. This signals that despite profit-taking and short-term volatility, momentum remains strong with...

CVR Partners announced strong third-quarter 2025 results, reporting US$163.55 million in sales and US$43.07 million in net income, along with a quarterly cash distribution of US$4.02 per common unit to be paid in November. This performance comes despite slightly lower production volumes compared to the prior year, highlighting improved margins and returns to unitholders. We'll explore how the company's significant earnings growth and dividend increase shape its investment narrative and...

We wouldn't blame Cimpress plc ( NASDAQ:CMPR ) shareholders if they were a little worried about the fact that Maarten...

Matrix Service Company's ( NASDAQ:MTRX ) price-to-sales (or "P/S") ratio of 0.4x may look like a pretty appealing...

Wondering if Super Micro Computer’s stock price is finally at a sweet spot or still running hot? You’re not alone. There’s plenty to dig into before making a decision. The stock has delivered a jaw-dropping 1312.8% return over five years and is still up 34.2% this year. However, it has pulled back sharply with a 26.8% drop in the past month alone. Much of this recent volatility has been driven by news highlighting surging demand for Super Micro’s AI-optimized servers, along with...

On October 28, 2025, Renasant Corporation announced a new US$150 million share repurchase program, revealed a quarterly dividend increase to US$0.23 per share, and released third-quarter earnings showing higher net interest income but lower net income compared to the prior year. This combination of capital return initiatives and mixed financial results may signal continued management confidence alongside emerging credit and earnings trends. We'll examine how Renasant’s launch of a...

Sangamo Therapeutics (SGMO) investors are watching closely after the company received a 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price rule, alleviating immediate delisting concerns. The extension follows third quarter earnings that revealed sharply lower revenue and a wider net loss compared to last year. See our latest analysis for Sangamo Therapeutics. Sangamo Therapeutics has seen sustained downward pressure on its share price throughout the year, with...

The recent price decline of 11% in InspireMD, Inc.'s ( NASDAQ:NSPR ) stock may have disappointed insiders who bought...

Some AXT, Inc. ( NASDAQ:AXTI ) shareholders may be a little concerned to see that the Independent Director, David...

GoDaddy Inc.'s ( NYSE:GDDY ) stock was strong despite it releasing a soft earnings report last week. Our analysis...

With the business potentially at an important milestone, we thought we'd take a closer look at Prenetics Global...

BioLife Solutions (BLFS) shares have delivered a month of positive momentum, climbing nearly 3% and standing out among biotech peers. The stock’s moves come as investors keep a close watch on the company’s fundamentals and sector trends. See our latest analysis for BioLife Solutions. Momentum has been fairly steady for BioLife Solutions, with a 19% gain in its share price over the last 90 days. This hints at renewed optimism among investors. The company’s one-year total shareholder return...

The stock price didn't jump after GATX Corporation ( NYSE:GATX ) posted decent earnings last week. We did some digging...

Designer Brands Inc. ( NYSE:DBI ) shareholders will doubtless be very grateful to see the share price up 37% in the...

Rogers, fresh off its third quarter earnings report, updated investors with new guidance for the upcoming quarter. The company projects slight year-over-year sales growth but a sequential drop, along with earnings per share expected to be modest at best. See our latest analysis for Rogers. Following the latest results and fresh guidance, Rogers’ share price has bounced 20.3% over the past three months. However, its one-year total shareholder return remains down 24.6%. Recent volatility likely...

Vaxcyte (PCVX) just wrapped up a busy week, announcing upbeat final results from its VAX-24 infant Phase 2 trial, key pipeline milestones, a major manufacturing deal, and a new commercial leadership hire. See our latest analysis for Vaxcyte. Vaxcyte’s share price has been on a rollercoaster this year, with recent momentum picking up after the strong VAX-24 trial data and major new manufacturing deal. Despite a tough year-to-date share price return of -49.9% and a one-year total shareholder...